Correlation between in vitro growth rate and in vivo virulence in Aspergillus fumigatus

Medical Mycology

Volumn 43, Issue 5, 2005, Pages 397-401

  Paisley, Derek ^a   Robson, Geoffrey D ^b   Denning, David W ^a,c  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Amphotericin; Fitness; Genome; Resistance

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CORRELATION ANALYSIS; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH RATE; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LETHAL DOSE; LIQUID CULTURE; MICROBIOLOGICAL PARAMETERS; MOUSE; NONHUMAN; SPECTROPHOTOMETRY;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL GROWTH PROCESSES; MICE; VIRULENCE;

ASPERGILLUS FUMIGATUS;

EID: 22844450479     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780400005866     Document Type: Article

References (28)

1. Mellado E, Aufauvre-Brown A, Gow NA, Holden DW. The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions. Mol Microbiol 1996; 20: 667-679.
2. Mellado E, Specht CA, Robbins PW, Holden DW. Cloning and characterization of chsD, a chitin synthase-like gene of Aspergillus fumigatus. FEMS Microbiol Lett 1996; 143: 69-76.
3. Aufauvre-Brown A, Mellado E, Gow NAR, Holden DW. Aspergillus fumigatus chsE: A gene related to CHS3 of Saccharomyces cerevisiae and important for hyphal growth and conidiophore development but not pathogenicity. Fungal Genet Biol 1997; 21: 141-152.
4. Trinci AP. A study of the kinetics of hyphal extension and branch initiation of fungal mycelia. J Gen Microbiol 1974; 81: 225-236.
5. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994; 140: 2475-2479.
6. Schnurer J. Comparison of methods for estimating the biomass of three food-borne fungi with different growth patterns. Appl Environ Microbiol 1993; 59: 552-555.
7. Magan N. Early detection of fungi in stored grain. Int Biodeter Biodegrad 1993; 32: 145-160.
8. Trinci, APJ. Culture turbidity as a parameter of mould growth. Trans Br Mycol Soc 1972; 58: 467-473.
9. Granade TC, Hehmann MF, Artis WM. Monitoring of filamentous fungal growth by in situ microspectrophotometry, fragmented mycelium absorbance density, and 14C incorporation: alternatives to mycelial dry weight. Appl Environ Microbiol 1985; 49: 101-108.
10. Meletiadis J, Mouton JW, Meis JF, Verweij PE. Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol 2001; 39: 478-484.
11. Meletiadis J, te Dorsthorst DT, Verweij PE. Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol 2003; 41: 4718-4725.
12. Denning DW, Venkateswarlu K, Oakley K, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364-1368.
13. Oakley KL, Morrissey G, Denning DW. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1504-1507.
14. Denning DW, Radford SA, Oakley K, et al. Correlation between in vitro susceptibility testing to itraconazole and in vivo outcome for Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
15. Verweij PE, Oakley KL, Morrissey J, et al. Efficacy of LY303366 against amphotericin B 'susceptible' and 'resistant' A. fumigatus infection in a murine model of invasive aspergillosis. Antimicrob Agents Chemother 1998; 42: 873-878.
16. Denning DW, Warn P. Dose range evaluation of liposomal nystatin and comparison with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B. Antimicrob Agents Chemother 1999; 43: 2592-2599.
17. Johnson E, Oakley KL, Radford S, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome of in a murine model of Aspergillus infection. J Antimicrob Chemother 1999; 45: 85-93.
18. Cowen LE, Kohn LM, Anderson JB. Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 2001; 183: 2971-2978.
19. Macvanin M, Bjorkman J, Erikson S, et al. Fusidic acid-resistant mutants of Salmonella enterica serovar Typimurium with low fitness in vivo are defective in RpoS induction. Antimicrob Agents Chemother 2003; 47: 3743-3749.
20. Sanchez P, Linares JF, Ruiz-Diez B, et al. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicob Chemother 2002; 50: 657-664.
21. Carr J, Ives J, Kelly L, et al. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res 2002; 54: 79-89.
22. Panepinto JC, Oliver BG, Fortwendel JR, et al. Deletion of the Aspergillus fumigatus gene encoding the Ras-related protein RhbA reduces virulence in a model of invasive pulmonary aspergillosis. Infect Immun 2003; 71: 2819-2826.
23. Rhodes JC, Oliver BG, Askew DS, Amlung TW. Identification of genes of Aspergillus fumigatus up-regulated during growth on endothelial cells. Med Mycol 200; 39: 253-260.
24. Liebmann B, Gattung S, Jahn B, Brakhage AA. cAMP signaling in Aspergillus fumigatus is involved in the regulation of the virulence gene pksP and in defense against killing by macrophages. Mol Genet Genomics 2003; 269: 420-435.
25. Graham BS, Tucker WS Jr. Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984; 101: 334-338.
26. Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991; 46: 15-20.
27. Diamond RD. Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J Infect Dis 1983; 147: 160.
28. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985; 76: 1755-1764.